As I've written repeatedly in recent months, the U.S. stock market is extremely overvalued, with an expected return over the next decade that is well below the rate of inflation. Bonds also appear to ...

Financials: The Mar '25 30 Year T-Bond is Higher by 12 ticks and trading at 113.25. Indices: The Mar '25 S&P 500 emini ES ...

DOW’s recent Q3 earnings delivered disappointing results due to a variety of headwinds. Click here to find out why I ...

CNBC's Jim Cramer on Thursday thought it worthwhile to review ten stocks that led the Dow Jones Industrial Average over the past year, including 3M and Amgen.

The Dow Jones rose on Thursday while the S&P 500 and Nasdaq built more support at the 50-day moving average in the stock ...

Follow all the latest U.S. market action for Tuesday as stocks stage a recovery amid lingering tariff angst; Alphabet ...

But with this sort of tailwind already blowing, this drug-development technology provider could conceivably make its way out of the red and into the black within the next 10 years. To say the ...

Earnings per share (EPS) missed analyst estimates by 15%. Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals ...

KeyBanc analyst Aleksey Yefremov maintained a Hold rating on Dow Inc (DOW ... revenue of $10.88 billion and a net profit of $211 million. In comparison, last year the company earned a revenue ...

Dow Inc. DOW recorded a loss (on a reported basis) of $53 million or 8 cents per share in fourth-quarter 2024, narrower than a loss of $105 million or 15 cents per share a year ago. On an adjusted ...